ClinTrial Research, LLC

ClinTrial Research, LLC, based in the US, delivers extensive clinical trial management services aimed at biotechnology, pharmaceutical, and medical device sectors, focusing on enhancing the clinical development process and patient engagement. ClinTrial Research, LLC is a provider of clinical trial management services that operates from its headquarters in Durham, US. Founded in 2024, the company has completed 1 deal as of December 17, 2025. The founder's detailed history is not publicly available, nor is there any mention of previous companies they may have established.

ClinTrial Research specializes in providing comprehensive clinical trial management services, focusing on the biotechnology, pharmaceutical, and medical device industries. Their core offerings encompass clinical trial design, patient recruitment, site management, data management, and regulatory affairs consulting. These services aim to streamline the clinical development process, enhance patient engagement, and ensure compliance with regulatory standards. The company serves a diverse client base, including major pharmaceutical companies, emerging biotech firms, and academic institutions, facilitating the development of innovative therapies and medical solutions.

ClinTrial Research operates primarily in North America and Europe, targeting markets that are pivotal for clinical advancements. ClinTrial Research generates revenue through a combination of service contracts and partnerships with its clients. Transactions typically occur through fee-for-service agreements, where clients pay for tailored services based on their specific trial needs. The company may also engage in long-term contracts with clients that include bundled services for multiple trials, enabling a more integrated approach to clinical development.

Pricing structures are based on the complexity and scope of the services provided, including factors such as the number of sites involved and the duration of the trials. Their flagship services, designed to optimize trial efficiency and patient recruitment, are integral to their revenue model, reflecting the company's commitment to facilitating the successful development of new medical products. In December 2025, Tarsadia Investments led an investment in ClinTrial Research, LLC, with financial terms undisclosed. This investment will enable the company to enhance its resources and business development, paving the way for future growth initiatives.

ClinTrial Research plans to launch new products aimed at improving clinical trial processes, with specific release dates yet to be announced. The company also aims to expand its operations into new geographic regions, though details on which specific markets are targeted remain unclear.